Internal Medicine · Santa Ana, CA
NPI
1063527976
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2740 S Bristol St, Suite 208
Santa Ana, CA, 92704
Phone (714) 979-5734
Groups this clinician bills Medicare through
Medicare paid, 2024
$211K
2,442 services
Medicare patients, 2024
608
Average age 71
Drug cost, 2024
$3.9M
37,424 prescriptions
Company payments, 2025
$121
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ajay G Meka was code 99214 (office e&m - established), 1,096 times for 474 patients. In total Ajay G Meka billed 2,442 services in 38 codes, and Medicare paid $211K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-07-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,096 | 474 | $102.82 | $113K |
| 96372 Injection Administration | Office | 164 | 106 | $11.88 | $1,949 |
| 99497 Care Management/Coordination | Office | 156 | 153 | $71.22 | $11K |
| 99443 Telephone Services | Office | 144 | 71 | $106.44 | $15K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 137 | 90 | $0.90 | $123 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 127 | 127 | $145.72 | $19K |
| 99442 Telephone Services | Office | 94 | 81 | $71.18 | $6,691 |
| 99441 Telephone Services | Office | 78 | 65 | $47.68 | $3,719 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 75 | 61 | $253.05 | $19K |
| 93000 Electrocardiogram | Office | 68 | 59 | $10.57 | $719 |
| 99213 Office E&M - Established | Office | 56 | 35 | $61.43 | $3,440 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 36 | 35 | $173.96 | $6,263 |
| 81002 Clinical Chemistry | Office | 34 | 28 | $3.41 | $116 |
| 99215 Office E&M - Established | Office | 28 | 25 | $156.40 | $4,379 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 20 | 14 | $0.45 | $8.98 |
By year: 2022 $122K for 1,644 services; 2023 $149K for 1,919 services; 2024 $211K for 2,442 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 34 | 28 | $3.41 | $116 |
| 82962 Clinical Chemistry | 18 | 15 | $3.21 | $57.78 |
Medicare prescription drug claims, 2024
In 2024, the drug Ajay G Meka prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,355 prescriptions and refills. In total Ajay G Meka wrote 37,424 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,355 | 6,336 | 838 | $24K |
| Metformin Hcl Generic | 1,894 | 4,921 | 620 | $16K |
| Losartan Potassium Generic | 1,819 | 4,810 | 576 | $19K |
| Lisinopril Generic | 1,573 | 4,211 | 517 | $12K |
| Amlodipine Besylate Generic | 1,530 | 4,062 | 521 | $8,489 |
| Omeprazole Generic | 1,109 | 2,748 | 404 | $12K |
| Levothyroxine Sodium Generic | 878 | 2,346 | 300 | $13K |
| Hydrochlorothiazide Generic | 705 | 1,864 | 250 | $3,029 |
| Alendronate Sodium Generic | 677 | 1,559 | 205 | $5,754 |
| Glipizide Generic | 651 | 1,709 | 199 | $11K |
| Tamsulosin Hcl Generic | 643 | 1,763 | 238 | $9,256 |
| Gabapentin Generic | 639 | 1,358 | 227 | $8,630 |
| Simvastatin Generic | 593 | 1,540 | 183 | $4,909 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 526 | 796 | 193 | $23K |
| Diclofenac Sodium Generic | 521 | 921 | 205 | $51K |
Brand drugs: 4,373 claims; generic drugs: 32,210 claims; opioid claims: 168.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ajay G Meka $121 ($121 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbott Laboratories with $71.53.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.